Random Thoughts on this photo. I consider this to be a near perfect
photo. Look at the colors. From the sky to the wood the Monarch
Butterfly is perched on to everything else, the colors harmonize as
one. The butterfly seems to hold the sun.
Banking Committee Chairman Christopher Dodd (D-Conn.) is a sell-out to
the banks. He has taken the stance that he is working hard for
financial reform. He is lying! The biggest money-making business the
big banks are in is derivative swaps. They account for trillions of
dollars more than our whole economy. They are the riskiest investments
that played a major part in the crash. Blanche Lincoln, not my
favorite Senator, introduced an amendment that would require banks to
trade derivatives through a clearing house so as to make the sales
much more transparent. Banking Committee Chairman Christopher Dodd
(D-Conn.) removed all the guts from that Amendment! There is no
penalty for banks to avoid the clearinghouse and continue to trade in
the dark. There is no guarantee that any clearinghouse would have to
accept the derivatives. There is just plain no teeth in the Amendment.
Banking Committee Chairman Christopher Dodd (D-Conn.) removed all the
teeth from the Amendment - a Dentist for the banks. MOST IMPORTANT,
this is the MOST IMPORTANT PART OF THE WHOLE FINANCIAL REGULATION
BILL. MOST PEOPLE WILL NOT NOTICE IT, BUT DODD HAS SCREWED AMERICA
ROYALLY and the banks will be forever grateful UNLESS Obama puts the
teeth back in. The more public exposure this fact gets, the better.
Banking Committee Chairman Christopher Dodd (D-Conn.) is a traitor to
the Democratic Party and the people of America and a flunky for the
Banks.
Australian scientists are seeking volunteers
online to help them better understand sexual attraction. At a specially
created website —www.bodylab.biz — users can go online and make their
own ratings of computer-generated avatar images of men and women of
greatly varying shapes, sizes, and proportions. The bodyLab team will
analyse and compile the results
The drug dichloroacetate (DCA) has finally finished its first clinical
trial against brain tumours in humans. Drug companies weren't willing
to test a drug they could not patent, so money was raised in the
community
through donations, auctions, and finally government support, but the
study was still limited to five patients, showing extremely positive
results in four of them. It also raises the question of where all the
money donated to Canadian and other cancer societies, and especially
the
billions spent buying merchandise with little pink ribbons on it goes,
if not to actual cancer research like this."
trial against brain tumours in humans. Drug companies weren't willing
to test a drug they could not patent, so money was raised in the
community
through donations, auctions, and finally government support, but the
study was still limited to five patients, showing extremely positive
results in four of them. It also raises the question of where all the
money donated to Canadian and other cancer societies, and especially
the
billions spent buying merchandise with little pink ribbons on it goes,
if not to actual cancer research like this."
